Boston Scientific Completes Acquisition of Relievant Medsystems

  Recent coverage of Intracept in the healthcare plan® system expands access to vertebrogenic pain treatment to tens of millions of patients MARLBOROUGH, Mass., Nov. 17, 2023 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of Relievant Medsystems Inc., a company offering the only U.S. Food and Drug Administration-approved…